Clinical Neuromuscular Pathology Certification Examination Committee Contributors
Mazen Mohammad Dimachkie, MD, Chair, University of Kansas Medical Center
Disclosures: Received compensation for services as a consultant to Abcuro, Amazentis/Vandria, ArgenX, Astellas, Catalyst, Cello, CNSA, Covance/Labcorp, CSL-Behring, Dianthus, EcoR1, EMD Serono/Merck, Janssen, Kezar, MDA, Medlink, Momenta, NuFactor, Octapharma, Priovant, RaPharma/UCB, Roivant Sciences Inc, Sanofi Genzyme, Shire Takeda, Scholar Rock, Spark Therapeutics, TACT, Abata/Third Rock, and UCB Biopharma; receive compensation for serving on LABCORP/COVANCE as DMC member; received research grant support from Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, Corbus, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Kezar, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Octapharma, Orphazyme, Ra Pharma/UCB, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, The Myositis Association, UCB Biopharma/RaPharma, Viromed/Healixmith & TMA; receive royalties from UPTODATE.
Michelle Lynn Mauermann, MD, Vice Chair, Mayo Clinic – Rochester
Disclosures: Received research support from Alnylam and IONIS pharmaceuticals for clinical trials; received Oxford publishing royalties for Autonomic Disorders book
Rocio Carolina Garcia Santibanez, MD, Emory Brain Health Center
Disclosures: Nothing to disclose.
Ahmed Mohamed Attia El-Dokla, MD, NY Neuromuscular Healthcare, PC
Disclosures: Nothing to disclose.
Shalini Mahajan, MD, Cedars-Sinai Medical Center
Disclosures: Received research grant from Dysimmune Diseases Foundation.
Raghav Govindarajan, MD, St. Elizabeth Medical Group, Illinois
Disclosures: Received personal compensation for serving as a consultant for Janssen, UCB, Argenx, Amylyx; received personal compensation for serving on a scientific advisory or data safety monitoring board for DSMB, chair for Apellis; received personal compensation for serving on a speakers’ bureau for Argenx, Alexion, Abbvie, and Biohaven; received royalties from Taylor and Francis
Margherita Milone, MD, PhD, Mayo Clinic – Rochester
Disclosures: Received personal compensation for serving as a consultant for Argenx: one time board meeting participation for treatment of myasthenia gravis; consulting service for treatment of DOK-7 congenital myasthenic syndrome; received personal compensation for serving as Associate editor of Neurology Genetics; received research support from MDA, Minnesota Regenerative Medicine, and Mayo Clinic.
Aziz Shaibani, MD, Nerve and Muscle Center of Texas
Disclosures: Nothing to disclose.
Anthony A. Amato, MD, Brigham and Women's Hospital
Disclosures: Received personal compensation for serving as a consultant on medical advisory boards for Johnson & Johnson, Abcuro; received compensation for serving on a scientific advisory or data safety monitoring board for FDA; received personal compensation for serving as Associate Editor for Neurology; received research support as site PI on several research trials: Abcuro, Pharnext.
Mohamed Kazamel, MD, University of Alabama at Birmingham
Disclosures: Receives compensation for being a consultant for Alnylam Pharmaceuticals, including expertise on acute hepatic porphyria.